{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:23:54Z","timestamp":1790767434797,"version":"4.1.0"},"reference-count":116,"publisher":"The Company of Biologists","issue":"2","license":[{"start":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T00:00:00Z","timestamp":1612828800000},"content-version":"vor","delay-in-days":374,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009358","name":"Duchenne UK","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009358","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Save Our Sons Duchenne Foundation"},{"DOI":"10.13039\/100013465","name":"French Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["20602"],"award-info":[{"award-number":["20602"]}],"id":[{"id":"10.13039\/100013465","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Muscular Dystrophy Western Australia"},{"DOI":"10.13039\/100015742","name":"Forrest Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015742","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009928","name":"Higher Committee For Education Development in Iraq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009928","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,2,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>Duchenne muscular dystrophy (DMD) is a lethal, X-linked disease that causes severe loss of muscle mass and function in young children. Promising therapies for DMD are being developed, but the long lead times required when using clinical outcome measures are hindering progress. This progress would be facilitated by robust molecular biomarkers in biofluids, such as blood and urine, which could be used to monitor disease progression and severity, as well as to determine optimal drug dosing before a full clinical trial. Many candidate DMD biomarkers have been identified, but there have been few follow-up studies to validate them. This Review describes the promising biomarkers for dystrophic muscle that have been identified in muscle, mainly using animal models. We strongly focus on myonecrosis and the associated inflammation and oxidative stress in DMD muscle, as the lack of dystrophin causes repeated bouts of myonecrosis, which are the key events that initiate the resultant severe dystropathology. We discuss the early events of intrinsic myonecrosis, along with early regeneration in the context of histological and other measures that are used to quantify its incidence. Molecular biomarkers linked to the closely associated events of inflammation and oxidative damage are discussed, with a focus on research related to protein thiol oxidation and to neutrophils. We summarise data linked to myonecrosis in muscle, blood and urine of dystrophic animal species, and discuss the challenge of translating such biomarkers to the clinic for DMD patients, especially to enhance the success of clinical trials.<\/jats:p>","DOI":"10.1242\/dmm.043638","type":"journal-article","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T16:15:16Z","timestamp":1583165716000},"source":"Crossref","is-referenced-by-count":124,"title":["Biomarkers for Duchenne muscular dystrophy: myonecrosis, inflammation and oxidative stress"],"prefix":"10.1242","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4530-9402","authenticated-orcid":false,"given":"Miranda D.","family":"Grounds","sequence":"first","affiliation":[{"name":"School of Human Sciences, the University of Western Australia 1 , Perth, WA 6009 , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica R.","family":"Terrill","sequence":"additional","affiliation":[{"name":"School of Molecular Sciences, the University of Western Australia 2 , Perth, WA 6009 , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basma A.","family":"Al-Mshhdani","sequence":"additional","affiliation":[{"name":"School of Molecular Sciences, the University of Western Australia 2 , Perth, WA 6009 , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa N.","family":"Duong","sequence":"additional","affiliation":[{"name":"School of Molecular Sciences, the University of Western Australia 2 , Perth, WA 6009 , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah G.","family":"Radley-Crabb","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Biomedical Sciences, Curtin Health and Innovation Research Institute 3 , Faculty of Health Sciences , , Perth, WA 6102 , Australia"},{"name":"Curtin University 3 , Faculty of Health Sciences , , Perth, WA 6102 , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Arthur","sequence":"additional","affiliation":[{"name":"School of Molecular Sciences, the University of Western Australia 2 , Perth, WA 6009 , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"237","published-online":{"date-parts":[[2020,3,2]]},"reference":[{"key":"2024061010065382300_DMM043638C1","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.3233\/JND-150102","article-title":"Circulating biomarkers for Duchenne muscular dystrophy","volume":"2","author":"Aartsma-Rus","year":"2015","journal-title":"J. Neuromuscul. Dis."},{"key":"2024061010065382300_DMM043638C2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.nmd.2017.10.002","article-title":"226(th) ENMC International Workshop: Towards validated and qualified biomarkers for therapy development for Duchenne muscular dystrophy 20-22 January 2017, Heemskerk, The Netherlands","volume":"28","author":"Aartsma-Rus","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"2024061010065382300_DMM043638C3","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1152\/physrev.00007.2015","article-title":"Absence of Dystrophin disrupts skeletal muscle signaling: roles of Ca2+, reactive oxygen species, and nitric oxide in the development of muscular dystrophy","volume":"96","author":"Allen","year":"2016","journal-title":"Physiol. Rev."},{"key":"2024061010065382300_DMM043638C4","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.nmd.2004.08.004","article-title":"Albumin targeting of damaged muscle fibres in the mdx mouse can be monitored by MRI","volume":"14","author":"Amthor","year":"2004","journal-title":"Neuromuscul. Disord."},{"key":"2024061010065382300_DMM043638C5","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.freeradbiomed.2010.11.018","article-title":"A fluorescent dual labeling technique for the quantitative measurement of reduced and oxidized protein thiols in tissue samples","volume":"50","author":"Armstrong","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"2024061010065382300_DMM043638C6","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/j.1365-2125.2005.02435.x","article-title":"Biomarkers and surrogate endpoints","volume":"59","author":"Aronson","year":"2005","journal-title":"Br. J. Clin. Pharmacol."},{"key":"2024061010065382300_DMM043638C7","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/MCO.0b013e328302f3fe","article-title":"Oxidative stress as a therapeutic target during muscle wasting: considering the complex interactions","volume":"11","author":"Arthur","year":"2008","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"2024061010065382300_DMM043638C8","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1136\/archdischild-2017-314506","article-title":"Pharmacokinetic studies in children: recommendations for practice and research","volume":"103","author":"Barker","year":"2018","journal-title":"Arch. Dis. Child."},{"key":"2024061010065382300_DMM043638C9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1542\/pir.27-3-83","article-title":"Duchenne muscular dystrophy","volume":"27","author":"Biggar","year":"2006","journal-title":"Pediatr. Rev."},{"key":"2024061010065382300_DMM043638C10","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/(SICI)1097-0177(199911)216:3&lt;244::AID-DVDY3&gt;3.0.CO;2-9","article-title":"Patterns of repair of dystrophic mouse muscle: studies on isolated fibers","volume":"216","author":"Blaveri","year":"1999","journal-title":"Dev. Dyn."},{"key":"2024061010065382300_DMM043638C11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S1474-4422(09)70272-8","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol."},{"key":"2024061010065382300_DMM043638C12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.biocel.2018.03.016","article-title":"Expression patterns of regulatory RNAs, including lncRNAs and tRNAs, during postnatal growth of normal and dystrophic (mdx) mouse muscles, and their response to Taurine treatment","volume":"99","author":"Butchart","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"2024061010065382300_DMM043638C13","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1212\/01.wnl.0000173836.09176.c4","article-title":"Early onset of inflammation and later involvement of TGF\u03b2 in Duchenne muscular dystrophy","volume":"65","author":"Chen","year":"2005","journal-title":"Neurology"},{"key":"2024061010065382300_DMM043638C14","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/ki.2013.502","article-title":"Characterization and deep sequencing analysis of exosomal and non-exosomal miRNA in human urine","volume":"86","author":"Cheng","year":"2014","journal-title":"Kidney Int."},{"key":"2024061010065382300_DMM043638C15","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.molmed.2017.09.002","article-title":"Biomarker Potential of Extracellular miRNAs in Duchenne muscular dystrophy","volume":"23","author":"Coenen-Stass","year":"2017","journal-title":"Trends Mol. Med."},{"key":"2024061010065382300_DMM043638C16","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1089\/ars.2012.4702","article-title":"Redox albuminomics: oxidized albumin in human diseases","volume":"17","author":"Colombo","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"2024061010065382300_DMM043638C17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1365-2990.1988.tb00866.x","article-title":"The mdx mouse skeletal muscle myopathy: I. A histological, morphometric and biochemical investigation","volume":"14","author":"Coulton","year":"1988","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"2024061010065382300_DMM043638C18","doi-asserted-by":"publisher","first-page":"891972","DOI":"10.1155\/2015\/891972","article-title":"Systemic inflammation in Duchenne muscular dystrophy: association with muscle function and nutritional status","volume":"2015","author":"Cruz-Guzman Odel","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"2024061010065382300_DMM043638C19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0022-510X(75)90232-4","article-title":"Stages in fibre breakdown in Duchenne muscular dystrophy. An electron-microscopic study","volume":"24","author":"Cullen","year":"1975","journal-title":"J. Neurol. Sci."},{"key":"2024061010065382300_DMM043638C20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/prca.201300072","article-title":"Fibronectin is a serum biomarker for Duchenne muscular dystrophy","volume":"8","author":"Cynthia Martin","year":"2014","journal-title":"Proteomics Clin. Appl."},{"key":"2024061010065382300_DMM043638C21","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1083\/jcb.201402079","article-title":"Asynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophy","volume":"207","author":"Dadgar","year":"2014","journal-title":"J. Cell Biol."},{"key":"2024061010065382300_DMM043638C22","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1042\/BJ20151227","article-title":"Protein oxidation and peroxidation","volume":"473","author":"Davies","year":"2016","journal-title":"Biochem. J."},{"key":"2024061010065382300_DMM043638C23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.cyto.2017.12.006","article-title":"Identification of plasma interleukins as biomarkers for deflazacort and omega-3 based Duchenne muscular dystrophy therapy","volume":"102","author":"de Carvalho","year":"2018","journal-title":"Cytokine"},{"key":"2024061010065382300_DMM043638C24","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1080\/14737159.2019.1648214","article-title":"Emerging proteomic biomarkers of X-linked muscular dystrophy","volume":"19","author":"Dowling","year":"2019","journal-title":"Expert Rev. Mol. Diagn."},{"key":"2024061010065382300_DMM043638C25","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1016\/j.freeradbiomed.2005.12.037","article-title":"Protein thiol oxidation in health and disease: techniques for measuring disulfides and related modifications in complex protein mixtures","volume":"40","author":"Eaton","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"2024061010065382300_DMM043638C26","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3109\/10715762.2011.590136","article-title":"Screening for increased protein thiol oxidation in oxidatively stressed muscle tissue","volume":"45","author":"El-Shafey","year":"2011","journal-title":"Free Radic. Res."},{"key":"2024061010065382300_DMM043638C27","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0140-6736(02)07815-7","article-title":"The muscular dystrophies","volume":"359","author":"Emery","year":"2002","journal-title":"Lancet"},{"key":"2024061010065382300_DMM043638C28","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1399-3011.1988.tb00900.x","article-title":"Further studies on the resolution of human mercapt- and nonmercaptalbumin and on human serum albumin in the elderly by high-performance liquid chromatography","volume":"31","author":"Era","year":"1988","journal-title":"Int. J. Pept. Protein Res."},{"key":"2024061010065382300_DMM043638C29","doi-asserted-by":"publisher","first-page":"18168","DOI":"10.3390\/molecules201018168","article-title":"Duchenne muscular dystrophy: from diagnosis to therapy","volume":"20","author":"Falzarano","year":"2015","journal-title":"Molecules"},{"key":"2024061010065382300_DMM043638C30","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/mus.24167","article-title":"Muscle atrophy, ubiquitin-proteasome, and autophagic pathways in dysferlinopathy","volume":"50","author":"Fanin","year":"2014","journal-title":"Muscle Nerve"},{"key":"2024061010065382300_DMM043638C31","volume-title":"Considerations for Use of Histopathology and its Associated Methodologies to Support Biomarker Qualification","author":"FDA","year":"2016"},{"key":"2024061010065382300_DMM043638C32","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/0022-510X(81)90018-6","article-title":"Embryonic and foetal myosins in human skeletal muscle. The presence of foetal myosins in duchenne muscular dystrophy and infantile spinal muscular atrophy","volume":"52","author":"Fitzsimons","year":"1981","journal-title":"J. Neurol. Sci."},{"key":"2024061010065382300_DMM043638C33","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1212\/WNL.35.5.758","article-title":"Activity. creatine kinase, and myoglobin in Duchenne muscular dystrophy: a clue to etiology?","volume":"35","author":"Florence","year":"1985","journal-title":"Neurology"},{"key":"2024061010065382300_DMM043638C35","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3233\/JND-180324","article-title":"\u201cOf mice and measures\u201d: a project to improve how we advance Duchenne muscular dystrophy therapies to the clinic","volume":"5","author":"Gordish-Dressman","year":"2018","journal-title":"J. Neuromuscul. Dis."},{"key":"2024061010065382300_DMM043638C36","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1096\/fj.08-128579","article-title":"Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia","volume":"23","author":"Greco","year":"2009","journal-title":"FASEB J."},{"key":"2024061010065382300_DMM043638C37","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1007\/s00018-008-7574-8","article-title":"Two-tiered hypotheses for Duchenne muscular dystrophy","volume":"65","author":"Grounds","year":"2008","journal-title":"Cell Mol. Life Sci."},{"key":"2024061010065382300_DMM043638C38","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.biocel.2014.09.010","article-title":"The need to more precisely define aspects of skeletal muscle regeneration","volume":"56","author":"Grounds","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"2024061010065382300_DMM043638C39","first-page":"3758","article-title":"Chemotaxis in myogenesis","volume":"7","author":"Grounds","year":"1996","journal-title":"Mol. Biol. Cell"},{"key":"2024061010065382300_DMM043638C40","doi-asserted-by":"publisher","first-page":"e0205926","DOI":"10.1371\/journal.pone.0205926","article-title":"Cycles of myofiber degeneration and regeneration lead to remodeling of the neuromuscular junction in two mammalian models of Duchenne muscular dystrophy","volume":"13","author":"Haddix","year":"2018","journal-title":"PLoS ONE"},{"key":"2024061010065382300_DMM043638C41","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/j.1365-2125.2012.04272.x","article-title":"The antioxidant paradox: less paradoxical now?","volume":"75","author":"Halliwell","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"2024061010065382300_DMM043638C42","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1046\/j.0021-8782.2001.00008.x","article-title":"Evans Blue Dye as an in vivo marker of myofibre damage: optimising parameters for detecting initial myofibre membrane permeability","volume":"200","author":"Hamer","year":"2002","journal-title":"J. Anat."},{"key":"2024061010065382300_DMM043638C43","doi-asserted-by":"publisher","first-page":"6458","DOI":"10.1093\/hmg\/ddu366","article-title":"Discovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients","volume":"23","author":"Hathout","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"2024061010065382300_DMM043638C44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12014-016-9109-x","article-title":"Clinical utility of serum biomarkers in Duchenne muscular dystrophy","volume":"13","author":"Hathout","year":"2016","journal-title":"Clin. Proteomics"},{"key":"2024061010065382300_DMM043638C45","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/00001756-199612200-00070","article-title":"Oxidative damage to muscle protein in Duchenne muscular dystrophy","volume":"8","author":"Haycock","year":"1996","journal-title":"Neuroreport"},{"key":"2024061010065382300_DMM043638C46","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.nmd.2006.06.011","article-title":"Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFalpha function with Etanercept in mdx mice","volume":"16","author":"Hodgetts","year":"2006","journal-title":"Neuromuscul. Disord."},{"key":"2024061010065382300_DMM043638C47","doi-asserted-by":"publisher","first-page":"e4638","DOI":"10.3390\/ijms20184638","article-title":"miRNA Profiling for early detection and treatment of Duchenne muscular dystrophy","volume":"20","author":"Hrach","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"2024061010065382300_DMM043638C48","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1016\/j.freeradbiomed.2013.09.024","article-title":"Visualizing and quantifying oxidized protein thiols in tissue sections: a comparison of dystrophic mdx and normal skeletal mouse muscles","volume":"65","author":"Iwasaki","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"2024061010065382300_DMM043638C49","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/elps.1150100707","article-title":"Elevated plasma levels of haptoglobin in Duchenne muscular dystrophy:electrophoretic variants in patients with a severe form of the disease","volume":"10","author":"John","year":"1989","journal-title":"Electrophoresis"},{"key":"2024061010065382300_DMM043638C50","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/0009-8981(79)90076-7","article-title":"Catalase, superoxide dismutase, glutathione reductase and thiobarbituric acid-reactive products in normal and dystrophic human muscle","volume":"94","author":"Kar","year":"1979","journal-title":"Clin. Chim. Acta"},{"key":"2024061010065382300_DMM043638C51","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.freeradbiomed.2004.09.013","article-title":"Immunogenicity of a brominated protein and successive establishment of a monoclonal antibody to dihalogenated tyrosine","volume":"38","author":"Kato","year":"2005","journal-title":"Free Radic. Biol. Med."},{"key":"2024061010065382300_DMM043638C52","doi-asserted-by":"publisher","first-page":"965631","DOI":"10.1155\/2014\/965631","article-title":"Understanding the process of fibrosis in Duchenne muscular dystrophy","volume":"2014","author":"Kharraz","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"2024061010065382300_DMM043638C53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10974-012-9330-9","article-title":"Contribution of oxidative stress to pathology in diaphragm and limb muscles with Duchenne muscular dystrophy","volume":"34","author":"Kim","year":"2013","journal-title":"J. Muscle Res. Cell Motil."},{"key":"2024061010065382300_DMM043638C54","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12979-019-0151-1","article-title":"Cytokines for evaluation of chronic inflammatory status in ageing research: reliability and phenotypic characterisation","volume":"16","author":"Koelman","year":"2019","journal-title":"Immun. Ageing"},{"key":"2024061010065382300_DMM043638C55","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13395-017-0124-z","article-title":"The golden retriever model of Duchenne muscular dystrophy","volume":"7","author":"Kornegay","year":"2017","journal-title":"Skelet. Muscle"},{"key":"2024061010065382300_DMM043638C56","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s41584-018-0005-9","article-title":"Biomarkers as drug development tools: discovery, validation, qualification and use","volume":"14","author":"Kraus","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"2024061010065382300_DMM043638C57","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.joca.2015.03.002","article-title":"OARSI clinical trials recommendations: soluble biomarker assessments in clinical trials in osteoarthritis","volume":"23","author":"Kraus","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"key":"2024061010065382300_DMM043638C58","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1093\/jnen\/nlw019","article-title":"A neurogenic perspective of Sarcopenia: time course study of sciatic nerves from aging mice","volume":"75","author":"Krishnan","year":"2016","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"2024061010065382300_DMM043638C59","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.ajpath.2016.01.002","article-title":"Serum osteopontin as a novel biomarker for muscle regeneration in Duchenne muscular dystrophy","volume":"186","author":"Kuraoka","year":"2016","journal-title":"Am. J. Pathol."},{"key":"2024061010065382300_DMM043638C60","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1021\/pr0501259","article-title":"So, you want to look for biomarkers (introduction to the special biomarkers issue)","volume":"4","author":"LaBaer","year":"2005","journal-title":"J. Proteome Res."},{"key":"2024061010065382300_DMM043638C61","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1152\/japplphysiol.01325.2007","article-title":"Single bouts of exercise affect albumin redox state and carbonyl groups on plasma protein of trained men in a workload-dependent manner","volume":"104","author":"Lamprecht","year":"2008","journal-title":"J. Appl. Physiol."},{"key":"2024061010065382300_DMM043638C62","doi-asserted-by":"publisher","first-page":"e110371","DOI":"10.1371\/journal.pone.0110371","article-title":"Characterization of dystrophin deficient rats: a new model for Duchenne muscular dystrophy","volume":"9","author":"Larcher","year":"2014","journal-title":"PLoS ONE"},{"key":"2024061010065382300_DMM043638C63","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1038\/mtna.2014.29","article-title":"Circulating muscle-specific miRNAs in Duchenne muscular dystrophy patients","volume":"3","author":"Li","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"2024061010065382300_DMM043638C64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10715762.2019.1708347","article-title":"Oxidation of cysteine 34 of plasma albumin as a biomarker of oxidative stress","volume":"54","author":"Lim","year":"2020","journal-title":"Free Radic. Res."},{"key":"2024061010065382300_DMM043638C65","doi-asserted-by":"publisher","first-page":"17888","DOI":"10.1038\/s41598-017-17982-y","article-title":"Evaluation of serum MMP-9 as predictive biomarker for antisense therapy in Duchenne","volume":"7","author":"Lourbakos","year":"2017","journal-title":"Sci. Rep."},{"key":"2024061010065382300_DMM043638C66","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/0022-510X(84)90150-3","article-title":"Lipid peroxidation and superoxide dismutase activity in muscle and erythrocytes in Duchenne muscular dystrophy","volume":"63","author":"Mechler","year":"1984","journal-title":"J. Neurol. Sci."},{"key":"2024061010065382300_DMM043638C67","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0022-510X(87)90007-4","article-title":"Vascular endothelial cell injury and platelet embolism in Duchenne muscular dystrophy at the preclinical stage","volume":"82","author":"Miike","year":"1987","journal-title":"J. Neurol. Sci."},{"key":"2024061010065382300_DMM043638C68","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.cca.2019.04.005","article-title":"Titin in muscular dystrophy and cardiomyopathy: urinary titin as a novel marker","volume":"495","author":"Misaka","year":"2019","journal-title":"Clin. Chim. Acta"},{"key":"2024061010065382300_DMM043638C69","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1373\/clinchem.2016.268425","article-title":"Characterization of a blood spot creatine kinase skeletal muscle isoform immunoassay for high-throughput newborn screening of Duchenne muscular dystrophy","volume":"63","author":"Moat","year":"2017","journal-title":"Clin. Chem."},{"key":"2024061010065382300_DMM043638C70","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1038\/s41467-018-06057-9","article-title":"Necroptosis mediates myofibre death in dystrophin-deficient mice","volume":"9","author":"Morgan","year":"2018","journal-title":"Nat. Commun."},{"key":"2024061010065382300_DMM043638C71","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.nmd.2011.05.011","article-title":"Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD)","volume":"21","author":"Nadarajah","year":"2011","journal-title":"Neuromuscul. Disord."},{"key":"2024061010065382300_DMM043638C72","doi-asserted-by":"publisher","first-page":"e85216","DOI":"10.1371\/journal.pone.0085216","article-title":"Cys34-cysteinylated human serum albumin is a sensitive plasma marker in oxidative stress-related chronic diseases","volume":"9","author":"Nagumo","year":"2014","journal-title":"PLoS ONE"},{"key":"2024061010065382300_DMM043638C73","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1042\/CS20180157","article-title":"Implications of plasma thiol redox in disease","volume":"132","author":"Oliveira","year":"2018","journal-title":"Clin. Sci."},{"key":"2024061010065382300_DMM043638C74","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1161\/ATVBAHA.112.301172","article-title":"Angiogenic impairment of the vascular endothelium: a novel mechanism and potential therapeutic target in muscular dystrophy","volume":"33","author":"Palladino","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2024061010065382300_DMM043638C75","doi-asserted-by":"publisher","first-page":"e0194225","DOI":"10.1371\/journal.pone.0194225","article-title":"Combined use of protein biomarkers and network analysis unveils deregulated regulatory circuits in Duchenne muscular dystrophy","volume":"13","author":"Parolo","year":"2018","journal-title":"PLoS ONE"},{"key":"2024061010065382300_DMM043638C76","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/WCO.0b013e32834aa3f1","article-title":"Impending therapies for Duchenne muscular dystrophy","volume":"24","author":"Partridge","year":"2011","journal-title":"Curr. Opin. Neurol."},{"key":"2024061010065382300_DMM043638C77","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1111\/febs.12267","article-title":"The mdx mouse model as a surrogate for Duchenne muscular dystrophy","volume":"280","author":"Partridge","year":"2013","journal-title":"FEBS J."},{"key":"2024061010065382300_DMM043638C78","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1021\/cb900258z","article-title":"Orchestrating redox signaling networks through regulatory cysteine switches","volume":"5","author":"Paulsen","year":"2010","journal-title":"Acs Chem. Biol."},{"key":"2024061010065382300_DMM043638C80","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/mus.880050111","article-title":"Serum creatine kinase in the detection of Duchenne muscular dystrophy carriers: effects of season and multiple testing","volume":"5","author":"Percy","year":"1982","journal-title":"Muscle Nerve"},{"key":"2024061010065382300_DMM043638C81","doi-asserted-by":"publisher","first-page":"7093","DOI":"10.1113\/JP274229","article-title":"Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy","volume":"595","author":"Pinniger","year":"2017","journal-title":"J. Physiol."},{"key":"2024061010065382300_DMM043638C82","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.nbd.2006.03.016","article-title":"Cromolyn administration (to block mast cell degranulation) reduces necrosis of dystrophic muscle in mdx mice","volume":"23","author":"Radley","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"2024061010065382300_DMM043638C83","doi-asserted-by":"publisher","first-page":"RRN1276","DOI":"10.1371\/currents.RRN1276","article-title":"The different impact of a high fat diet on dystrophic mdx and control C57Bl\/10 mice","volume":"3","author":"Radley-Crabb","year":"2011","journal-title":"PLoS Curr."},{"key":"2024061010065382300_DMM043638C84","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.nmd.2011.07.008","article-title":"A single 30 min treadmill exercise session is suitable for \u2018proof-of concept studies\u2019 in adult mdx mice: a comparison of the early consequences of two different treadmill protocols","volume":"22","author":"Radley-Crabb","year":"2012","journal-title":"Neuromuscul. Disord."},{"key":"2024061010065382300_DMM043638C85","doi-asserted-by":"publisher","first-page":"e89277","DOI":"10.1371\/journal.pone.0089277","article-title":"Dystropathology increases energy expenditure and protein turnover in the mdx mouse model of duchenne muscular dystrophy","volume":"9","author":"Radley-Crabb","year":"2014","journal-title":"PLoS ONE"},{"key":"2024061010065382300_DMM043638C86","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J."},{"key":"2024061010065382300_DMM043638C87","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s11064-011-0683-z","article-title":"Oxidative damage in muscular dystrophy correlates with the severity of the pathology: role of glutathione metabolism","volume":"37","author":"Renjini","year":"2012","journal-title":"Neurochem. Res."},{"key":"2024061010065382300_DMM043638C88","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1006\/exmp.1994.1025","article-title":"Modifications in myotendinous junction surface morphology in dystrophin-deficient mouse muscle","volume":"61","author":"Ridge","year":"1994","journal-title":"Exp. Mol. Pathol."},{"key":"2024061010065382300_DMM043638C89","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1006\/excr.1993.1199","article-title":"The role of macrophages in skeletal muscle regeneration with particular reference to chemotaxis","volume":"207","author":"Robertson","year":"1993","journal-title":"Exp. Cell Res."},{"key":"2024061010065382300_DMM043638C90","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.nmd.2018.03.008","article-title":"High urinary ferritin reflects myoglobin iron evacuation in DMD patients","volume":"28","author":"Rouillon","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"2024061010065382300_DMM043638C91","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1093\/clinchem\/46.10.1703","article-title":"A sensitive assay of tumor necrosis factor alpha in sera from Duchenne muscular dystrophy patients","volume":"46","author":"Saito","year":"2000","journal-title":"Clin. Chem."},{"key":"2024061010065382300_DMM043638C92","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/BF00687539","article-title":"Segmental fibre breakdown and defects of the plasmalemma in diseased human muscles","volume":"33","author":"Schmalbruch","year":"1975","journal-title":"Acta Neuropathol."},{"key":"2024061010065382300_DMM043638C93","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.yexcr.2013.12.020","article-title":"Biomarkers in rare neuromuscular diseases","volume":"325","author":"Scotton","year":"2014","journal-title":"Exp. Cell Res."},{"key":"2024061010065382300_DMM043638C94","doi-asserted-by":"publisher","first-page":"476","DOI":"10.4049\/jimmunol.1900307","article-title":"Eosinophils Do Not Drive Acute Muscle Pathology in the mdx Mouse Model of Duchenne Muscular Dystrophy","volume":"203","author":"Sek","year":"2019","journal-title":"J. Immunol."},{"key":"2024061010065382300_DMM043638C95","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/mus.24998","article-title":"Increased collagen cross-linking is a signature of dystrophin-deficient muscle","volume":"54","author":"Smith","year":"2016","journal-title":"Muscle Nerve"},{"key":"2024061010065382300_DMM043638C96","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0022-3476(59)80033-0","article-title":"Activity of serum aldolase and lactic dehydrogenase in patients affected with Duchenne muscular dystrophy and in their immediate relatives","volume":"54","author":"Soltan","year":"1959","journal-title":"J. Pediatr."},{"key":"2024061010065382300_DMM043638C97","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/jcsm.12304","article-title":"Tracking disease progression non-invasively in Duchenne and Becker muscular dystrophies","volume":"9","author":"Spitali","year":"2018","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"2024061010065382300_DMM043638C98","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1083\/jcb.139.2.375","article-title":"Animal models for muscular dystrophy show different patterns of sarcolemmal disruption","volume":"139","author":"Straub","year":"1997","journal-title":"J. Cell Biol."},{"key":"2024061010065382300_DMM043638C99","doi-asserted-by":"publisher","first-page":"dmm032201","DOI":"10.1242\/dmm.032201","article-title":"A novel rabbit model of Duchenne muscular dystrophy generated by CRISPR\/Cas9","volume":"11","author":"Sui","year":"2018","journal-title":"Dis. Model Mech."},{"key":"2024061010065382300_DMM043638C100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/DNND.S121099","article-title":"Biomarkers of Duchenne muscular dystrophy: current findings","volume":"8","author":"Szigyarto","year":"2018","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"key":"2024061010065382300_DMM043638C101","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.nmd.2011.11.007","article-title":"N-Acetylcysteine treatment of dystrophic mdx mice results in protein thiol modifications and inhibition of exercise induced myofibre necrosis","volume":"22","author":"Terrill","year":"2012","journal-title":"Neuromuscul. Disord."},{"key":"2024061010065382300_DMM043638C102","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1016\/j.biocel.2013.07.009","article-title":"Treatment with the cysteine precursor l-2-oxothiazolidine-4-carboxylate (OTC) implicates taurine deficiency in severity of dystropathology in mdx mice","volume":"45","author":"Terrill","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"2024061010065382300_DMM043638C103","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.1111\/febs.12142","article-title":"Oxidative stress and pathology in muscular dystrophies: focus on protein thiol oxidation and dysferlinopathies","volume":"280","author":"Terrill","year":"2013","journal-title":"FEBS J."},{"key":"2024061010065382300_DMM043638C104","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.redox.2016.08.016","article-title":"Levels of inflammation and oxidative stress, and a role for taurine in dystropathology of the golden retriever muscular dystrophy dog model for Duchenne muscular dystrophy","volume":"9","author":"Terrill","year":"2016","journal-title":"Redox Biol."},{"key":"2024061010065382300_DMM043638C105","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1113\/JP271418","article-title":"Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy","volume":"594","author":"Terrill","year":"2016","journal-title":"J. Physiol."},{"key":"2024061010065382300_DMM043638C106","doi-asserted-by":"publisher","DOI":"10.1371\/ecurrents.md.77be6ec30e8caf19529a00417614a072","article-title":"Increased taurine in pre-weaned juvenile mdx mice greatly reduces the acute onset of myofibre necrosis and dystropathology and prevents inflammation","volume":"8","author":"Terrill","year":"2016","journal-title":"PLoS Curr."},{"key":"2024061010065382300_DMM043638C107","doi-asserted-by":"publisher","first-page":"e0187317","DOI":"10.1371\/journal.pone.0187317","article-title":"Beneficial effects of high dose taurine treatment in juvenile dystrophic mdx mice are offset by growth restriction","volume":"12","author":"Terrill","year":"2017","journal-title":"PLoS ONE"},{"key":"2024061010065382300_DMM043638C108","doi-asserted-by":"publisher","first-page":"e0219507","DOI":"10.1371\/journal.pone.0219507","article-title":"Discovery of potential urine-accessible metabolite biomarkers associated with muscle disease and corticosteroid response in the mdx mouse model for Duchenne","volume":"14","author":"Thangarajh","year":"2019","journal-title":"PLoS ONE"},{"key":"2024061010065382300_DMM043638C109","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/cphy.c170052","article-title":"Immunobiology of inherited muscular dystrophies","volume":"8","author":"Tidball","year":"2018","journal-title":"Compr. Physiol."},{"key":"2024061010065382300_DMM043638C110","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41582-019-0203-3","article-title":"Therapeutic developments for Duchenne muscular dystrophy","volume":"15","author":"Verhaart","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"2024061010065382300_DMM043638C111","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.tins.2012.04.004","article-title":"The dystrophin-glycoprotein complex in brain development and disease","volume":"35","author":"Waite","year":"2012","journal-title":"Trends Neurosci."},{"key":"2024061010065382300_DMM043638C112","doi-asserted-by":"publisher","first-page":"dmm035774","DOI":"10.1242\/dmm.035774","article-title":"Tracking progress: an update on animal models for Duchenne muscular dystrophy","volume":"11","author":"Wells","year":"2018","journal-title":"Dis. Model Mech."},{"key":"2024061010065382300_DMM043638C113","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1177\/0192623317734823","article-title":"Duchenne and Becker muscular dystrophies: a review of animal models, clinical end points, and biomarker quantification","volume":"45","author":"Wilson","year":"2017","journal-title":"Toxicol. Pathol."},{"key":"2024061010065382300_DMM043638C114","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0300-483X(02)00286-X","article-title":"Biological reactivity and biomarkers of the neutrophil oxidant, hypochlorous acid","volume":"181-182","author":"Winterbourn","year":"2002","journal-title":"Toxicology"},{"key":"2024061010065382300_DMM043638C116","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/BF00311386","article-title":"Dystrophin and a dystrophin-related protein in intrafusal muscle fibers, and neuromuscular and myotendinous junctions","volume":"84","author":"Zhao","year":"1992","journal-title":"Acta Neuropathol"},{"key":"2024061010065382300_DMM043638C117","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/NEN.0b013e3181e9a34b","article-title":"Targeting fibrosis in Duchenne muscular dystrophy","volume":"69","author":"Zhou","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"2024061010065382300_DMM043638C118","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/eci.12582","article-title":"Plasma protein thiols: an early marker of oxidative stress in asthma and chronic obstructive pulmonary disease","volume":"46","author":"Zinellu","year":"2016","journal-title":"Eur. J. Clin. Invest."},{"key":"2024061010065382300_DMM043638C119","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3389\/fphys.2015.00338","article-title":"Redox characterization of functioning skeletal muscle","volume":"6","author":"Zuo","year":"2015","journal-title":"Front. Physiol."}],"container-title":["Disease Models &amp; Mechanisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1242\/dmm.043638","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.biologists.com\/dmm\/article-pdf\/doi\/10.1242\/dmm.043638\/3469119\/dmm043638.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.biologists.com\/dmm\/article-pdf\/doi\/10.1242\/dmm.043638\/3469119\/dmm043638.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T10:11:06Z","timestamp":1718014266000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.biologists.com\/dmm\/article\/13\/2\/dmm043638\/225293\/Biomarkers-for-Duchenne-muscular-dystrophy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,1]]},"references-count":116,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2,1]]}},"URL":"https:\/\/doi.org\/10.1242\/dmm.043638","relation":{},"ISSN":["1754-8411","1754-8403"],"issn-type":[{"value":"1754-8411","type":"electronic"},{"value":"1754-8403","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2,1]]},"article-number":"dmm043638"}}